CL
Clene Inc.
CLNNW · NASDAQ
$0.00 -28.00% (-$0.00)
Market Cap $2.16M
P/E Ratio -
Div. Yield -
ROE 351.16%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 10.11x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 82.24%
Net margin 14,250.50%
Op. margin 11,328.50%
Quality
30 /100
Poor ROIC 151.07%
ROE 351.16%
ROA 136.69%
Debt
66 /100
Moderate Current ratio 1.53x
Int. coverage -11.44x
Net debt/EBITDA -0.51x
Stability
55 /100
Moderate Beta 0.79x
EPS volatility 46.31%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CLNNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Etherington
Employees
75
Headquarters
Salt Lake City